IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.536
NA - Nord America 11.891
EU - Europa 4.238
SA - Sud America 1.917
AF - Africa 226
Continente sconosciuto - Info sul continente non disponibili 172
OC - Oceania 55
AN - Antartide 1
Totale 34.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.320
SG - Singapore 8.507
CN - Cina 2.722
HK - Hong Kong 2.230
IT - Italia 2.058
BR - Brasile 1.393
VN - Vietnam 776
GB - Regno Unito 675
FR - Francia 544
BD - Bangladesh 416
CA - Canada 274
DE - Germania 262
IN - India 227
AR - Argentina 186
ID - Indonesia 134
NL - Olanda 120
MX - Messico 104
EC - Ecuador 102
CO - Colombia 95
TR - Turchia 80
ZA - Sudafrica 80
UA - Ucraina 75
JP - Giappone 74
ES - Italia 62
IQ - Iraq 58
RU - Federazione Russa 53
AU - Australia 50
PL - Polonia 45
CL - Cile 40
FI - Finlandia 38
PY - Paraguay 36
SA - Arabia Saudita 36
CZ - Repubblica Ceca 33
MA - Marocco 32
AT - Austria 31
JM - Giamaica 31
CR - Costa Rica 30
SE - Svezia 30
PK - Pakistan 28
PE - Perù 26
VE - Venezuela 26
GT - Guatemala 24
PH - Filippine 24
RO - Romania 24
EG - Egitto 23
HN - Honduras 23
MD - Moldavia 23
PT - Portogallo 22
TN - Tunisia 22
UZ - Uzbekistan 20
SV - El Salvador 19
MY - Malesia 16
KZ - Kazakistan 15
NP - Nepal 15
IL - Israele 14
JO - Giordania 14
KE - Kenya 13
LT - Lituania 13
NI - Nicaragua 13
TH - Thailandia 13
TT - Trinidad e Tobago 13
IE - Irlanda 12
IR - Iran 12
OM - Oman 12
DK - Danimarca 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
BG - Bulgaria 10
EE - Estonia 10
LB - Libano 10
PR - Porto Rico 10
DZ - Algeria 9
AZ - Azerbaigian 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GP - Guadalupe 8
KR - Corea 8
BE - Belgio 7
GR - Grecia 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
AD - Andorra 6
CW - ???statistics.table.value.countryCode.CW??? 6
KW - Kuwait 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BO - Bolivia 5
CG - Congo 5
GH - Ghana 5
HU - Ungheria 5
LU - Lussemburgo 5
LV - Lettonia 5
QA - Qatar 5
SN - Senegal 5
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
TW - Taiwan 4
Totale 33.784
Salva come PNG Salva come JPEG
Città #
San Jose 2.945
Ashburn 2.744
Hong Kong 2.200
Singapore 1.721
Rome 1.307
Hefei 1.104
Council Bluffs 789
Boardman 620
Columbus 576
London 527
Beijing 491
Lauterbourg 473
Dallas 362
Shanghai 361
Ho Chi Minh City 298
Santa Clara 181
New York 179
Hanoi 152
Los Angeles 148
Phoenix 140
São Paulo 115
Pune 97
San Francisco 96
Toronto 80
Amsterdam 78
Washington 64
Naples 63
Munich 61
Milan 60
Seattle 57
Tokyo 53
Mexico City 48
Montreal 45
Atlanta 43
Chicago 41
Brasília 40
Brooklyn 40
Denver 39
Haiphong 37
Warsaw 37
Frankfurt am Main 36
Las Vegas 35
Rio de Janeiro 35
Buffalo 34
Da Nang 34
Guayaquil 33
Baghdad 31
Ankara 29
Bari 29
Quito 29
Johannesburg 28
San José 24
Stockholm 24
Turin 24
Turku 23
Biên Hòa 22
Guangzhou 22
Porto Alegre 22
Bogotá 21
Boston 21
Curitiba 21
Nuremberg 21
Buenos Aires 20
Chennai 20
Medellín 20
Thái Bình 20
West Jordan 20
Brno 19
Florence 19
Cape Town 18
Hải Dương 18
Jinan 18
Manchester 18
Belo Horizonte 17
Bologna 17
Campinas 17
Guatemala City 17
Kingston 17
Philadelphia 17
San Salvador 17
Sydney 17
Vienna 17
Guarulhos 16
Hangzhou 16
Lima 16
Tashkent 16
The Dalles 16
Charlotte 15
Jakarta 15
Palermo 15
Riyadh 15
Changsha 14
Manaus 14
San Antonio 14
Can Tho 13
Dhaka 13
Helsinki 13
Madrid 13
Managua 13
Melbourne 13
Totale 19.733
Salva come PNG Salva come JPEG
Nome #
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 276
------- 249
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 241
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 237
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 231
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 227
A comprehensive review on adult onset Still's disease 225
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 218
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 214
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 213
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 210
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 205
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 201
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 200
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 198
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 197
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 197
Adult-onset Still's disease with elderly onset: results from a multicentre study 187
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 184
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 179
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 179
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 178
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 178
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 174
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 167
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 151
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 135
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 132
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 130
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 127
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 127
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 126
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 124
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 124
Recent advances and evolving concepts in Still's disease 123
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease 123
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 123
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 122
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 121
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 119
Cytokine storm syndrome in severe COVID-19 118
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 117
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 114
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 113
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 112
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 112
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 110
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model 110
Development and implementation of the AIDA International Registry for patients with Behçet's disease 109
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 109
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 107
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 104
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 103
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 103
Polyclonal B lymphocyte activation in progressive systemic sclerosis. 102
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 102
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 101
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 101
The economic burden of fibromyalgia: A systematic literature review 99
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 99
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 99
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 98
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 98
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 96
Cardiovascular disease in primary sjögren’s syndrome 96
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 94
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 91
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 90
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 89
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 87
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 87
Vascular complications of scleroderma 85
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 83
The Vessels Contribute to Fibrosis in Systemic Sclerosis 82
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 82
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 81
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 80
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 80
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 79
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 79
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 79
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 79
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 79
Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications 79
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 78
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 78
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 78
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 78
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 78
SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA 78
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 77
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 77
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 76
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 75
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 75
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 75
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 75
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 75
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 75
Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria 74
Totale 12.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.368
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022614 0 0 0 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/202616.151 1.556 496 1.216 2.243 456 944 4.069 1.311 1.231 1.258 801 570
2026/20274.266 183 1.433 1.246 1.404 0 0 0 0 0 0 0 0
Totale 34.036